PP
BMY icon

Pingora Partners’s Bristol-Myers Squibb BMY Stock Holding History

Pingora Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Hold
33,855
– – 1.14% 22
2026
Q1 		$2.05M Sell
33,855
-150
-0.4% -$8.74K 1.22% 16
2025
Q4 		$1.83M Buy
34,005
+7,825
+30% +$376K 1.12% 17
2025
Q3 		$1.18M Buy
26,180
+1,100
+4% +$51.4K 0.78% 28
2025
Q2 		$1.16M Buy
25,080
+2,270
+10% +$111K 0.87% 28
2025
Q1 		$1.39M Hold
22,810
– – 1.03% 24
2024
Q4 		$1.29M Buy
22,810
+576
+3% +$32.2K 0.85% 25
2024
Q3 		$1.15M Hold
22,234
– – 0.81% 25
2024
Q2 		$923K Sell
22,234
-800
-3% -$35.8K 0.65% 28
2024
Q1 		$1.25M Buy
23,034
+2,350
+11% +$120K 0.91% 25
2023
Q4 		$1.06M Buy
+20,684
New +$1.09M 0.94% 26

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pingora Partners's BMY Position: Q2 2026 in Review

Pingora Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 33,855 shares worth $1.95M. The position accounts for 1.14% of the portfolio, ranked #22.

Pingora Partners first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.05M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pingora Partners held 33,855 shares of Bristol-Myers Squibb worth $1.95M as of Q2 2026.
  • Pingora Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 1.14% of Pingora Partners's portfolio in Q2 2026, its #22 holding.
  • Pingora Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Pingora Partners's Bristol-Myers Squibb position peaked at $2.05M in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.